Compare ARK Genomic Revolution ETF (ARKG) vs VanEck Gold Miners ETF (GDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs VanEck Gold Miners ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while VanEck Gold Miners ETF trades at $74.43. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, VanEck Gold Miners ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | GDX | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $115.84 |
52-Week Low | $23.09 | $51.15 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GDX trades at $75.53, down 0.32% with a bearish technical signal from moving averages. The ETF faces near-term pressure from gold price volatility but maintains strong fundamentals with record-high free cash flow yields and attractive valuations at five-year lows according to Seeking Alpha analysis from June 25, 2026. Recent portfolio addition of Aya Gold & Silver enhances diversification.
Long-term outlook remains positive given gold's role as a portfolio diversifier and central bank demand. Key risks include gold price sensitivity and mining cost pressures. Analyst sentiment is mixed with some seeing current levels as a buying opportunity while technical indicators suggest caution in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About VanEck Gold Miners ETF
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →
